Viw Magazine

The Times


.

Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand

  • Written by Viw Magazine

Mounjaro® (tirzepatide) will be available in the market from the end of May 2025

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in Thailand at the end of May 2025.

Read more

LifeStyle

From Lot to the Open Road: How to Get Your Caravan Road Ready

Buying a caravan is the beginning of many new adventures, but before you can start travelling, the...

Salon-Approved Curly Hair Routines: How Professionals Actually Manage Frizz Beyond Brushes

Curly hair has a mind of its own. Some days the curls sit perfectly, and other days the same routine...

Human Hair Wigs: A Practical And Natural-Looking Hair Solution

Hair plays an important role in personal style, confidence, and self-expression. Whether experienc...

The SNUGGLES Cove: Premium 2-in-1 Hooded Pet Beds for Ultimate Comfort

Finding the right pet bedding can make a real difference to your pet’s comfort and daily routine. ...

hacklink hack forum hacklink film izle hacklink Vipparkสล็อตz library livrosjojobetvipparkjojobet108casibomstakeBetpipoPadişahbetHitbetjojobetsuperbetin girişStreamEastStreamEastmersin escortsüperbetPadişahbetjojobetjojobetcasino siteleriPadişahbetPadişahbetHerabettaraftarium24selcuksportstaraftarium24taraftarium24taraftarium24taraftarium24betnanobetpuantaraftarium24lidyabetDizipalStreamEastGalabet GirişmostbetTrBettaraftarium24Pituus Infojojobetjojobetcasibomtaraftarium24streameastjustin tvdizipalbetnanobetsmovebetsmovebetsmovejojobetjustin tvnakitbahismeritking